PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25785937-3	2015	Here we investigated whether a cyclooxygenase-2 (COX-2) inhibitor or diethylcarbamazine (DEC), that is known for its 5-lipoxygenase inhibiting and antioxidant actions, modify the development of PAH in the Sugen 5416/hypoxia (SuHx) rat model.	Diethylcarbamazine	69-87	arachidonate 5-lipoxygenase	Rattus norvegicus	117-131	
1400062-7	1992	The 5-lipoxygenase inhibitor diethylcarbamazine (DEC), administered before the PAF injection, inhibited the elevations of PAP and all LTs.	Diethylcarbamazine	29-47	arachidonate 5-lipoxygenase	Rattus norvegicus	4-18	
1400062-7	1992	The 5-lipoxygenase inhibitor diethylcarbamazine (DEC), administered before the PAF injection, inhibited the elevations of PAP and all LTs.	Diethylcarbamazine	49-52	arachidonate 5-lipoxygenase	Rattus norvegicus	4-18	
25785937-3	2015	Here we investigated whether a cyclooxygenase-2 (COX-2) inhibitor or diethylcarbamazine (DEC), that is known for its 5-lipoxygenase inhibiting and antioxidant actions, modify the development of PAH in the Sugen 5416/hypoxia (SuHx) rat model.	Diethylcarbamazine	89-92	arachidonate 5-lipoxygenase	Rattus norvegicus	117-131